Warts and squamous cell carcinomas in organ transplant patients: Is the human papillomavirus responsible for carcinogenesis?

European Journal of Dermatology

Volumn 7, Issue 1, 1997, Pages 5-11

  Chardonnet, Yvette ^a   Viac, Jacqueline ^a   Euvrard, Sylvie ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

HPV; human papillomavirus; immunosuppressive treatment; organ transplant recipients; squamous cell carcinoma; UV irradiation

Indexed keywords

HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ORGAN TRANSPLANTATION; REVIEW; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION; WART VIRUS;

EID: 0031015225     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Penn I. Tumors of the immunocompromised patient. Ann Rev Med 1988; 39: 63-73.
2. Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, O'Sullivan B, Siskind V, Van der Woude FJ, Hardie IR. The risk of skin cancer in renal transplant recipients in Queensland, Australia. Transplantation 1996; 61: 715-21.
3. Orth G. Epidermodysplasia verruciformis. Salzman NP, Howley P, éds. In: The Papovaviridae. Plenum Pub Corp, 1987; 2: 199-243.
4. Barr BBB, Benton EC, McLaren K, Bunney MH, Smith IW, Blessing K, Hunter JAA. Human papillomavirus infection and skin cancer in renal allograft recipients. Lancet 1989; 1: 124-9.
5. Hartvelt MM, Bouwes-Bavinck JN, Koote AMM, Vermeer BJ, Vandebroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49: 506-9.
6. Hardie IR, Strong RW, Hartley LCJ, Woodruff PWH, Clunie GJA. Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 1980; 87: 177-83.
7. Euvrard S, Kanitakis J, Pouteil-Noble C, Dureau G, Touraine JL, Faure M, Cloudy A, Thivolet J. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33: 222-9.
8. McLelland J, Rees A, Williams G, Chu T. The incidence of immunosuppression-related skin disease in long-term transplant patients. Transplantation 1988; 46: 871-4.
9. Euvrard S, Chardonnet Y, Dureau G, Hermier C, Thivolet J. Human papillomavirus type1-associated squamous cell carcinoma in a heart transplant recipient. Arch Dermatol 1991; 127: 559-64.
10. De Villiers EM. Human pathogenic papillomavirus types: an update. Cur Top Microbiol Immunol 1994; 186: 1-12.
11. Tommasino M, Crawford L. Human papillomavirus E6 and E7: proteins which deregulate the cell cycle. BioEssays 1995; 17: 509-18.
12. Stanley MA. Replication of human papillomaviruses in cell culture. Antiviral Res 1994; 24: 1-15.
13. Kao GF, Kao WH. Malignant transformation of keratinocytes by human papillomaviruses. J Cut Pathol 1994; 21: 193-9.
14. Fuchs PG, Pfister H. Transcription of papillomavirus genomes. Intervirology 1994; 37: 159-67.
15. Grussendorf EI, Zur Hausen H. Localization of viral DNA-replication in sections of human warts by nucleic acid hybridization with complementary RNA of human papilloma virus type 1. Arch Dermatol Res 1979; 264: 55-63.
16. Soler C, Chardonnet Y, Allibert P, Euvrard S, Schmitt D, Mandrand B. Detection of mucosal human papillomavirus types 6/11 in cutaneous lesions from transplant recipients. J Invest Dermatol 1993; 101: 286-91.
17. Stark LA, Arends MJ, McLaren KM, Benton EC, Shahidullah H, Hunter JAA, Bird CC. Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion. Br J Cancer 1994; 69: 222-9.
18. Rübben A, Krones R, Schwetschenau B, Grüssendorf-Conen EI. Common warts from immunocompetent patients show the same distribution of human papillomavirus types as common warts from immunocompromised patients. Br J Dermatol 1993; 28: 264-70.
19. Dürst M, Croce CM, Gissmann L, Schwartz E, Huebner K. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA 1987; 84: 1070-4.
20. Purdie KJ, Sexton CJ, Proby CM, Glover MT, Williams AT, Stables JN, Leigh IM. Malignant transformation of cutaneous lesions in renal allograft patients. A role for human papillomavirus. Cancer Res 1993; 53: 5328-33.
21. Bouwes Bavinck JN, Vermeer BJ, Claas FHJ, Ter Schegget J, Van der Woude FJ. Skin cancer and renal transplantation. J Nephrol 1994; 7: 261-7.
22. Bouwes Bavinck JN, Claas FJH. The role of HLA molecules in the development of skin cancer. Human Immunol 1994; 41: 173-9.
23. Czarnecki D, Watkins F, Leahy S, Dyall-Smith D, Levis A, Nicholson I, Taif B. Skin cancers and HLA frequencies in renal transplant recipients. Dermatology 1992; 185: 9-11.
24. Glover MT, Bodmer J, Bodmer W, Kennedy LJ, Brown J, Navarrete C, Kwan JTC, Leigh IM. HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer. Eur J Cancer 1993; 29A: 520-4.
25. España A, Redondo P, Fernandez AL, Zabala M, Herreros J, Llorens R, Quintanilla E. Skin cancer in heart transplant recipients. J Am Acad Dermatol 1995; 32: 458-65.
26. Viac J, Chardonnet Y, Chignol MC, Schmitt D. Papilloma viruses, warts, carcinoma and Langerhans cells. In Vivo 1993; 7: 207-12.
27. Jackson M, Benton EC, Hunter JJ, Norval M. Local immune responses in cutaneous warts: an immunocytochemical study of Langerhans' cells, T cells and adhesion molecules. Eur J Dermatol 1994; 4: 399-404.
28. Viac J, Schmitt D, Claudy A. Expression of adhesion receptors in epidermal tumors: correlation with TNFα expressing cells. Anticancer Res 1995; 15: 551-6.
29. Iwatsuki K, Tagami H, Takigawa M, Yamada M. Plane warts under spontaneous regression. Arch Dermatol 1986; 122: 655-9.
30. Markey AC, Churchill LJ, Allen MH, MacDonald DM. Activation and inducer subset phenotype of the lymphocytic infiltrate around epidermally derived tumors. J Am Acad Dermatol 1990; 23: 214-20.
31. Bergfelt L, Larko O, Blohmé I. Skin disease in immunosuppressed patients in relation to epidermal Langerhans' cells. Acta Dermatol Venereol 1993; 73: 330-4.
32. Viac J, Chardonnet Y, Euvrard S, Schmitt D. Epidermotropism of T cells correlates with intercellular adhesion molecule (ICAM1) expression in human papillomavirus (HPV) induced lesions. J Pathol 1992; 168: 301-6.
33. Malejczyk J, Malejczyk M, Köck A, Urbanski A, Majewski S, Hunzelmann N, Jablonska S, Orth G, Luger TA. Autocrine growth limitation of human papillomavirus type 16-harboring keratinocytes by constitutively released tumor necrosis factor α. J Immunol 1992; 149: 2702-8.
34. Kim J, Modlin RL, Moy RL, Dubinett SM, McHugh T, Nickoloff BJ, Uyemura K. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J Immunol 1995; 155: 2240-7.
35. Stingl G. The skin: initiation and target site of immune responses. Recent Results in Cancer Res 1993; 128: 45-57.
36. Streilin JW, Taylor JR, Vincek V, Kurimoto I, Shimizu T, Tie C, Golomb C. Immune surveillance and sunlight-induced skin cancer. Immunology Today 1994; 15: 174-9.
37. Cruz PD, Bergerstresser PR. Ultraviolet radiation, Langerhans' cells, and skin cancer. Arch Dermatol 1989; 125: 975-9.
38. Yoshikawa T, Rae V, Bruins-Slot W, Van den Berg JW, Taylor JR, Streilein JW. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol 1990; 95: 530-6.
39. Gupta AK, Cardella CJ, Haberman HF. Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol 1986; 122 :1288-93.
40. Simon MM, Sliutz G, Luger TA. Protoncogenes and oncogenes in epidermal neoplasia. Exp Dermatol 1995; 4: 65-73.
41. Campbell CC, Quinn AG, Rees JL. Codon 12 Harvey-ras mutations are rare events in non-melanoma human skin cancer. Br J Dermatol 1993; 128: 111-4.
42. Pierceall WE, Murkhopadhyay T, Goldberg LH, Ananthaswamy HN. Mutations in the p53 tumour suppressor gene in human cutaneous squamous cell carcinomas. Mol Carcinogenesis 1991; 4: 445-9.
43. Pélisson I, Chardonnet Y, Euvrard S, Schmitt D. Low incidence of c-Ha Ras mutations in benign and malignant cutaneous lesions from transplant recipients. Int J Cancer 1993; 55: 915-20.
44. Pélisson I, Soler C, Chignol MC, Euvrard S, Chardonnet Y. Papillomavirus humains et oncogènes cellulaires (c-myc, c-Ha-ras) dans les lésions cutanées et muqueuses des sujets transplantés. Bull Cancer 1992; 79: 471-82.
45. Ziegler A, Lefell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE, Brash DE. Mutation hotspots due to sunlight in the p53 gene of non-melanoma skin cancers. Proc Natl Acad Sci USA 1993; 90: 4216-20.
46. Basset-Seguin N, Molès JP, Mils V, Dereure O, Guilhou JJ. TP53 tumor suppressor gene and skin carcinogenesis. J Invest Dermatol 1994; 103: 102s-6s.
47. Stark LA, Arends MJ, McLaren KM, Benton EC, Shahidullah H, Hunter JAA, Bird CC. Accumulation of p53 is associated with tumour progression in cutaneous lesions of renal allograft recipients. Br J Cancer 1994; 70: 662-7.
48. McGregor JM, Farthing A, Crook T, Yu CCW, Dublin EA, Levison DA, Mac Donald DM. Post-transplant skin cancer: a possible role for p53 gene mutation but not for oncogenic human papillomaviruses. J Am Acad Dermatol 1994; 30: 701-6.
49. Inohara S, Kitagawa K, Kitano Y. Expression of cyclin D1 and p53 protein in various malignant skin tumors. Dermatology 1996; 192: 94-8.
50. Zerfass K, Schulze A, Spitkovsky D, Friedman V, Henglein B, Jansen-Dürr P. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J Virol 1995; 69: 6389-99.
51. Inohara S, Kitano Y, Kitagawa K. Cell cycle regulators in the keratinocyte (cyclin-cdk). Exp Dermatol 1995; 4: 1-8.
52. Kato M, Ishizaki A, Hellman U, Wernsted C, Kyogokut M, Miyazono K, Heldin CH, Funa K. A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-β and insulin-like growth factor binding protein-6, in a calcium- and cell density-dependent manner. J Biol Chem 1995; 270: 12373-9.
53. Banks L, Matlashewski G. Cell transformation and the HPV E5 gene. Papillomavirus Rep 1993; 4: 1-4.
54. Mckay IA, Winyard P, Leigh IM, Bustin SA. Nuclear transcription factors: potential targets for new modes of intervention in skin disease. Brit J Dermatol 1994; 131: 591-7.
55. Finco TS, Baldwin AS. Mechanistic aspects of NFκB regulation. The emerging role of phophorylation and proteolysis. Immunity 1995; 3: 263-72.
56. Jain J, McCaffrey PG, Valge-Archer VE, Rao A. Nuclear factor of activated T cells contains Fos and Jun. Nature 1992; 356: 801-4.
57. Simon MM, Aragane Y, Schwarte A, Luger TA, Schwarte T. UVB light induces nuclear factor κB (NFκB) activity independently from chromosomal DNA damage in cell-free cytosolic extracts. J Invest Dermatol 1994; 102: 422-7.
58. Fisher GJ, Datta SC, Talwar HS, Wang ZQ, Varani J, Kang S, Vorhees JJ. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996; 379: 335-9.
59. Corsini E, Bruccoleri A, Marinovich M, Galli CL. In vitro mechanism(s) of ultraviolet-induced tumor necrosis factor-α release in a human keratinocyte cell line. Photodermatol Photoimmunol Photomed 1995; 11: 112-8.
60. Karlen S, Offord EA, Beard P. Herpes simplex virions interfere with the expression of human papillomavirus type 18 genes. J Gen Virol 1993; 74: 965-73.
61. Zur Hausen H. Roots and perspectives of contemporary papillomavirus research. J Cancer Res Clin Oncol 1996; 122: 3-13.
62. Pfister H, Gross G, Hagedorn M. Characterization of human papillomavirus 3 in warts of a renal allograft patient. J Invest Dermatol 1979; 73: 349-53.
63. Lutzner M, Croissant O, Ducasse MF, Kreis H, Crosnier J, Orth G. Potentially oncogenic human papillomavirus (HPV5) found in two renal allograft recipients. J Invest Dermatol 1980; 75: 353-6.
64. Rüdlinger R, Smitn IW, Bunney MH, Hunter JAA. Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol 1986; 115: 681-92.
65. Gassenmaier A, Fuchs P, Schell H, Pfister H. Papillomavirus DNA in warts of immunosuppressed renal allograft recipients. Arch Dermatol Res 1986; 278: 219-23.
66. Bunney MH, Barr BB, McLaren K, Smith IW, Benton EC, Anderton JL, Hunter JAA. Human papillomavirus type 5 and skin cancer in renal allograft recipients. Lancet 1987; 2: 151-2.
67. Van der Leest RJ, Zachow KR, Ostrow RS, Bender M, Pass F, Faras AJ. Human papillomavirus heterogeneity in 36 renal transplant recipients. Arch Dermatol 1987; 123: 354-7.
68. Rüdlinger R, Bunney MH, Smith IW, Hunter JAA. Detection of a human papillomavirus type 5 DNA in a renal allograft patient from Scotland. Dermatologica 1988; 177: 280-6.
69. Blessing K, McLaren KM, Benton EC, Barr BBB, Bunney MH, Smith IW, Beveridge GW. Histopathology of skin lesions in renal allograft recipients - an assessment of viral features and dysplasia. Histopathology 1989; 14: 129-39.
70. Blessing K, McLaren KM, Morris R, Barr BBB, Benton EC, Alloub M, Bunney MH, Smith IW, Smart GE, Bird CC. Detection of human papillomavirus in skin and genital lesions of renal allograft recipients by in situ hybridization. Histopathology 1990; 16: 181-5.
71. Dyall-Smith D, Trowell H, Mark A, Dyall-Smith M. Benign human papillomavirus infection in renal transplant recipients. Int J Dermatol 1991; 30: 785-9.
72. Dyall-Smith D, Trowell H, Mark A, Dyall-Smith M. Cutaneous squamous cell carcinomas and papillomaviruses in renal transplant recipients: a clinical and molecular biological study. J Dermatol Sci 1991; 2: 139-46.
73. Smith S, Davis IC, Leshin B, Fleischer AB, White WL, Feldman SR. Absence of human papillomavirus in squamous cell carcinomas of nongenital skin from immunocompromised renal transplant patients. Arch Dermatol 1993; 129: 1585-8.
74. Tieben LM, Berkhout RJM, Smits HL, Bouwes-Bawinck JN, Vermeer BJ, Bruijn JA, Van der Woude FJ, Ter Schegget J. Detection of epidermodysplasia verruciformis-like human papillomavirus types in malignant and premalignant skin lesions of renal transplant recipients. Br J Dermatol 1994; 131: 226-30.
75. Shamanin V, Glover M, Rausch C, Proby C, Leigh IM, zur Hausen H, de Villiers EM. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 1994; 54: 4610-3.
76. Berkhout RJM, Tieben LM, Smits HL, Bouwes Bavinck JN, Vermeer BJ, Ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995; 33: 690-5.
77. De Jong-Tieben LM, Berkout RJM, Smits HL, Bouwes Bavinck JN, Vermeer BJ, Van der Woude FJ, Ter Schegget J. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995; 105: 367-71.
78. Goldberg LH, Griego RD. Absence of human papillomavirus in squamous cell carcinomas of nongenital skin from immunocompromised renal transplant patients: a comment. Arch Dermatol 1995; 131: 107.
79. Euvrard S, Chardonnet Y, Pouteil-Noble C, Kanitakis J, Chignol MC, Thivolet J, Touraine JL. Association of skin malignancies with various and multiple carcinogenic and non-carcinogenic human papillomaviruses in renal transplant recipients. Cancer 1993; 72: 2198-206.
80. Soler C, Allibert P, Chardonnet Y, Cros P, Mandrand B, Thivolet J. Detection of human papillomavirus types 6, 11, 16 and 18 in mucosal and cutaneous lesions by the multiplex polymerase reaction. J Virol Methods 1991; 35: 143-57.